Abera Bioscience
6,50 SEK
-2,26 %
Mindre end 1K følgere
ABERA
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Oversigt
Finansielt overblik og estimater
Ejerskab
Investorkonsensus
-2,26 %
+8,33 %
-19,75 %
-18,24 %
+44,12 %
+54,39 %
+32,52 %
-
-41,18 %
Abera Bioscience is active in biotechnology. The company specializes in the development of vaccines based on its own internal developed and patented platform. The technology is mainly used in the development of new vaccines where the focus is on the main areas of pneumococci and oncology. The business is located around the Nordic market. The company was founded in 2012 and is headquartered in Solna.
Læs mereMarkedsværdi
121,09 mio. SEK
Aktieomsætning
65 SEK
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Omsætning og EBIT-margin
Omsætning
EBIT-% (adj.)
EPS og udbytte
EPS (adj.)
Udbytte %
Finanskalender
12.2
2026
Årsrapport '25